Dexcom Launches Letter Campaign for Diabetes Month
The 'A Letter to Diabetes' campaign invites people living with the condition, their families, caregivers, and clinicians to share their experiences in November.
Updated on Nov. 2, 2026 in Diabetes
Dexcom launched the 'A Letter to Diabetes' campaign in November, timed to National Diabetes Awareness Month and World Diabetes Day. The campaign asks people with diabetes, family members, caregivers, and healthcare providers to write letters about their experiences.
Why it matters
The campaign gives people affected by diabetes a structured way to put their experiences into words during a month focused on awareness. Dexcom is a major maker of glucose monitoring devices, so the effort also raises the company's public profile.
Dexcom markets Stelo, its over-the-counter glucose biosensor, which launched in the U.S. in 2024 after FDA clearance for adults who do not use insulin. The extraction does not report campaign participation figures, and the company has not disclosed how many letters it expects to receive.
The players
Dexcom
Dexcom is a San Diego-based maker of continuous glucose monitoring systems that competes with Abbott's FreeStyle products.
Nick Jonas
Nick Jonas is a songwriter and actor who co-founded the advocacy group Beyond Type 1 and has lived with type 1 diabetes for years.
Chris Megino
Chris Megino is a creator who has built an online following by sharing his journey with type 2 diabetes.
Chelsea Lugone
Chelsea Lugone is a nurse practitioner and diabetes care and education specialist at Dexcom who lives with type 1 diabetes.
The details
Dexcom asks participants to put into words what they want to say about their diabetes journey, and it released letters written by participants, including songwriter Nick Jonas, who lives with type 1 diabetes. The company enlisted Jonas, Chris Megino, who has built an online following sharing his type 2 journey, and Chelsea Lugone, a nurse practitioner at Dexcom who lives with type 1 diabetes.
Timeline
2024: Dexcom's Stelo launched in the U.S. following FDA clearance.
November 2026: Dexcom launched the 'A Letter to Diabetes' campaign, timed to National Diabetes Awareness Month and World Diabetes Day.
Health Landscape
Dexcom's 2024 U.S. launch of Stelo, cleared by the FDA for adults who do not use insulin, marked a shift toward over-the-counter glucose monitoring. The 'A Letter to Diabetes' campaign extends that consumer push by using patient storytelling to build awareness around the condition.
People living with diabetes who use glucose monitors may see more over-the-counter options as Dexcom expands Stelo. Caregivers and family members can use the campaign's letter prompts to describe their own experiences managing the condition.
The takeaway
Writing about diabetes in your own words can help you and others understand daily management more clearly. Consider sharing your experience with a caregiver, family member, or clinician who supports your care.
Further reading
Explore more on Diabetes coverage for context on the condition and its management.
Source note: This article includes information reported by FiercePharma.
